HDVY Pengajuan SEC - Health Discovery Corporation- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

1141788

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Health Discovery Corporation

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

September 12, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 12, 2025 HEALTH DISCOVE UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 12, 2025 HEALTH DISCOVERY CORPORATION (Exact name of registrant as specified in charter) GA 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
September 12, 2025	EX-99.1	September 12, 2025 Exhibit 99.1 September 12, 2025 Dear Fellow Shareholders, I am writing to provide a straightforward update on what Health Discovery Corporation (“HDC”, or the “Company”) has been working on and how we are positioning the Company moving forward. In the near-term, our top priorities are protecting the value of our intellectual property (“IP”) and restoring our reporting with the Securities Exchange
September 18, 2024	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 13, 2024 HEALTH DISCOVERY CORPORATION (Exact name of registrant as specified in charter) GA 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
July 11, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 8, 2024 HEALTH DISCOVERY CORPORATION (Exact name of registrant as specified in charter) GA 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employer Id
June 6, 2024	EX-16.1	Securities and Exchange Commission Exhibit 16.1 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read the statements made by Health Discovery Corporation as filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of Health Discovery Corporation dated June 6, 2024. We agree with the statements concerning our Firm contained therein. Sincerely, /s/ Fr
June 6, 2024	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 31, 2024 HEALTH DISCOVERY CORPORATION (Exact name of registrant as specified in charter) GA 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employer Id
October 17, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 31, 2023 HEALTH DISCOVERY UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 31, 2023 HEALTH DISCOVERY CORPORATION (Exact name of registrant as specified in charter) GA 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employer
July 5, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 30, 2023 HEALTH DISCOVERY CO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 30, 2023 HEALTH DISCOVERY CORPORATION (Exact name of registrant as specified in charter) GA 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employer I
February 14, 2023	SC 13G/A	HDVY / Health Discovery Corporation / Citadel Securities GP LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* Health Discovery Corporation (Name of Issuer) Common Stock, no par value (the “Shares”) (Title of Class of Securities) 42218R100 (CUSIP Num
October 26, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 19, 2022 Health Discovery UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 19, 2022 Health Discovery Corporation (Exact name of registrant as specified in charter) GA 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employe
October 26, 2022	EX-99.1	October 19, 2022 Exhibit 99.1 October 19, 2022 George H. McGovern III Chairman and Chief Executive Officer Health Discovery Corporation PO Box 677 Berwyn, PA 19312 Re: Resignation Dear George, Please accept this notification of my resignation from the Board of Directors of Health Discovery Corporation, effective as of the date noted above. I am resigning from the Board for personal and family reasons. My resignati
June 22, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 15, 2022 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
June 22, 2022	EX-99.1	From: Marty Delmonte Exhibit 99.1 From: Marty Delmonte Date: June 15, 2022 at 11:35:33 AM EDT To: Board of Directors Subject: Resignation George: I hereby resign my position as President, COO and director from Health Discovery Corporation (?HDC? or the ?Company?) effective immediately. After twelve years of association and employment with HDC, the grave decisions you seem to have made unanimously on behalf of the Comp
April 6, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 5, 2022 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
April 6, 2022	EX-99.1	Health Discovery Corporation Files Infringement Suit Against Intel Corporation Exhibit 99.1 Health Discovery Corporation Files Infringement Suit Against Intel Corporation ATLANTA, Georgia, April 5, 2022 ? Health Discovery Corporation (?Health Discovery,? ?HDC? or the ?Company?), an intellectual property development company with an intellectual property portfolio using patent-protected technology, announced today that it refiled an infringement lawsuit (?Infringement Lawsuit?
April 5, 2022	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10D ? Form N-CEN ? Form N-CSR For Period Ended: December 31, 2021 ?Transition Report on Form 10-K ?Transition Report on Form 20-F ?Transition Report on Form 11-K ?Transition Report on Form 10-Q ?Transition Report on Form
March 30, 2022	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 24, 2022 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Empl
February 14, 2022	EX-99.1	JOINT FILING AGREEMENT EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the Shares of Health Discovery Corporation, a Georgia corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934, as amended, on behalf of each of the und
February 14, 2022	SC 13G	HDVY / Health Discovery Corporation / Citadel Securities GP LLC - HEALTH DISCOVERY CORP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 (Amendment No. )* Health Discovery Corporation (Name of Issuer) Common Stock, no par value (the ?Shares?) (Title of Class of Securities) 42218R100 (CUSIP Numb
December 28, 2021	EX-99.1	Case 6:20-cv-00666-ADA Document 66 Filed 12/27/21 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS WACO DIVISION Exhibit 99.1 Case 6:20-cv-00666-ADA Document 66 Filed 12/27/21 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS WACO DIVISION HEALTH DISCOVERY CORPORATION, Plaintiff, v. 6:20-cv-666-ADA INTEL CORPORATION, Defendant. MEMORANDUM OPINION AND ORDER GRANTING-IN-PART AND DENYING-AS-MOOT-IN-PART INTEL CORPORATION?S MOTION TO DISMISS [ECF No. 12] Came on for consideration this date is
December 28, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 27, 2021 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
November 15, 2021	10-Q	SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-62216 HEALTH DISCOVERY CORPORATION (Name of registrant as specified in its charter) Georgia 74-3002154 (State or other jurisdiction of Incorporation or Organization) (I.
August 13, 2021	10-Q	SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-62216 HEALTH DISCOVERY CORPORATION (Name of registrant as specified in its charter) Georgia GA 74-3002154 (State or other jurisdiction of Incorporation or Organization) (I.
July 6, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 29, 2021 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
June 4, 2021	EX-99.1	2 Term(s) and Asserted Claims Parties’ Agreed Construction “training” terms -- “training data,” “training set,” “training data set” and “training example” • ’188 patent (claims 1, 8, 9, 11, 13, 18, 19) • ’959 patent (claims 1, 12, 16) • ’483 patent ( Exhibit 99.1 Health Discovery Corporation Plaintiff, v. Intel Corporation Defendant. Civil Action No. 6:20 - cv - 00666 - ADA The Honorable Alan D. Albright JURY TRIAL DEMANDED UPDATED JOINT CLAIM CONSTRUCTION STATEMENT Pursuant to the Court?s December 21 , 2020 Scheduling Order (Dkt . No . 27 ), Plaintiff Health Discovery Corporation (?Plaintiff? or ?HDC?) and Defendant Intel Corporation (?Defend
June 4, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 3, 2021 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employ
June 4, 2021	EX-99.2	Term Plaintiff’s Proposed Construction Defendants’ Proposed Construction Court’s Final Construction “Data” Plain and Ordinary Meaning “biological data” Plain - and - ordinary meaning. • ’188 patent (claims 1, 8, 11, 13, 18, 19) • ’959 patent (claims Exhibit 99.2 HEALTH DISCOVERY CORPORATION, Plaintiff - v - INTEL CORPORATION, De f e n dant ? ? ? ? ? ? ? ? ? 6:20 - cv - 00666 - ADA CLAIM CONSTRUCTION ORDER The Court held a Markman hearing on June 3, 2021. During that hearing, the Court provided its final constructions. The Court now enters those claim constructions. SIGNED this 3rd day of June, 2021. ALAN D ALBRIGHT UNITED STATES DISTRICT JUDG
May 14, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly REPORT PURSUANT to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2021 or ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission File No. 333-62216 HEALT
May 7, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2021 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employe
April 9, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 6, 2021 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
April 9, 2021	EX-99.1	IN THE SUPERIOR COURT OF FULTON COUNTY BUSINESS CASE DIVISION STATE OF GEORGIA Exhibit 99.1 Fulton County Superior Court *EFILED*QW Date: 4/6/2021 5:03 PM Cathelene Robinson, Clerk IN THE SUPERIOR COURT OF FULTON COUNTY BUSINESS CASE DIVISION STATE OF GEORGIA CINDY BEAR, Plaintiff, v. HEALTH DISCOVERY CORPORATION, a Georgia corporation; GEORGE H. MCGOVERN, III; COLLEEN M. HUTCHINSON; WILLIAM F. FROMHOLZER; JAMES MURPHY; EDWARD MORRISON; MARTY DELMONTE and JAMES DENGLER,
March 19, 2021	EX-3.1 (E)	Articles of Amendment to Articles of Incorporation of the Registrant EXHIBIT 3.1 (e) ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF HEALTH DISCOVERY CORPORATION ARTICLE I. The name of the corporation is Health Discovery Corporation (the ?Corporation?). ARTICLE II. Effective as of May 27, 2020, Article Two of the Articles of Incorporation of the Corporation is amended to read as follows: ?2. Authorized Capital. The total number of shares of capital stock whic
March 19, 2021	10-K	Annual Report - FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x AnNUAL REPORT pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2020 or ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission File No. 333-62216 HEALTH DIS
March 19, 2021	EX-4.3	Description of the Company’s Capital Stock EXHIBIT 4.3 DESCRIPTION OF CAPITAL STOCK The following information concerning our capital stock summarizes certain provisions of our Articles of Incorporation, commonly referred to as our Charter, and Bylaws, as well as certain statutes regulating the rights of holders of our common stock. The information does not purport to be a complete description of such matters and is qualified in all respect
March 19, 2021	EX-3.1 (D)	Amended and Restated Articles of Amendment to Articles of Incorporation of the Registrant EXHIBIT 3.1(d) AMENDED AND RESTATED ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF HEALTH DISCOVERY CORPORATION 1. The name of the corporation is Health Discovery Corporation. 2. The Articles of Incorporation of Health Discovery Corporation are hereby amended to insert a new Section 2D ? Series D Preferred Stock, as follows: Section 2D. Series D Preferred Stock 1. Designation. The shares of
November 13, 2020	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly REPORT PURSUANT to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2020 or ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission File No. 333-62216 HEALTH DISCOVERY CO
September 30, 2020	8-K	Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 24, 2020 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS
August 14, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly REPORT PURSUANT to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2020 or ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission File No. 333-62216 HEALTH DISCOVERY CORPORA
July 23, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 23, 2020 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
July 23, 2020	EX-99.1	Health Discovery Corporation Files Infringement Suit Against Intel Corporation Exhibit 99.1 Health Discovery Corporation Files Infringement Suit Against Intel Corporation ATLANTA, Georgia, July 23, 2020 – Health Discovery Corporation (“Health Discovery”, “HDC” or the “Company”), an intellectual property development company with an intellectual property portfolio using patent protected advanced mathematical techniques, announced today that it has filed an infringement lawsuit
June 30, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly REPORT PURSUANT to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2020 or ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission File No. 333-62216 HEALTH DISCOVERY CORPOR
June 2, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 27, 2020 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employ
May 14, 2020	EX-3.2	Amended and Restated Bylaws of the Registrant EXHIBIT 3.2 AMENDMENT TO THE BYLAWS OF HEALTH DISCOVERY CORPORATION In accordance with resolutions adopted by the Board of Directors of Health Discovery Corporation, a Georgia corporation (the “Corporation”), the Bylaws of the Corporation (the “Bylaws”) are hereby amended as set forth in this Amendment to the Bylaws, effective May 8, 2020. AMENDMENT 1. Article Two, Section 1 of the Bylaws is delet
May 14, 2020	10-K/A	Annual Report - FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR o TRANSITION REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-62216 HEALTH DISCOVERY CORPORAT
May 14, 2020	EX-99.1	IN THE SUPERIOR COURT OF FULTON COUNTY STATE OF GEORGIA EXHIBIT 99.1 IN THE SUPERIOR COURT OF FULTON COUNTY STATE OF GEORGIA CINDY BEAR and WILLIAM F. ) QUIRK, JR., ) ) Plaintiffs, ) ) Civil Action No. v. ) ) 2020CV333862 HEALTH DISCOVERY ) CORPORATION, a Georgia corporation; ) GEORGE H. MCGOVERN, III; ) COLLEEN M. HUTCHINSON; ) WILLIAM F. FROMHOLZER; JAMES ) MURPHY; EDWARD MORRISON; ) MARTY DELMONTE and JAMES ) DENGLER, ) ) Defendants. MOTION TO WITHD
May 14, 2020	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 8, 2020 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employe
May 12, 2020	10-K	Annual Report - 10-K TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333
April 10, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 6, 2020 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
April 6, 2020	8-K	Changes in Registrant's Certifying Accountant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 17, 2019 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
March 30, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 30, 2020 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Empl
March 20, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 20, 2020 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Empl
March 6, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 5, 2020 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
February 13, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2020 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Em
January 7, 2020	8-K	Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 31, 2019 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
December 6, 2019	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 6, 2019 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Em
December 6, 2019	EX-99.1	2002 Summit Blvd, Suite 300 Atlanta, Georgia 30319 (404) 566-4865 EXHIBIT 99.1 2002 Summit Blvd, Suite 300 Atlanta, Georgia 30319 (404) 566-4865 December 6, 2019 Dear Fellow Shareholders: This is the first time that I have been able to communicate with you by a shareholder letter since I became Chairman and CEO of our company, Health Discovery Corporation (“HDC” or the “Company”). For those that I have not had the privilege of speaking with since my involvement
September 20, 2019	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 20, 2019 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS
June 14, 2019	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 10, 2019 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
April 26, 2019	EX-99.1	AMERICAN ARBITRATION ASSOCIATION Commercial Arbitration Under AAA Commercial Rules and Mediation Procedures Amended and effective October 1, 2013 Exhibit 99.1 AMERICAN ARBITRATION ASSOCIATION Commercial Arbitration Under AAA Commercial Rules and Mediation Procedures Amended and effective October 1, 2013 In the Matter of the Arbitration between: AAA Case No.: 01-17-007-6821 Health Discovery Corporation Claimant Represented by Kirk Watkins, Esq. of Davis, Zipperman, Kirschenbaum & Lotito v. NeoGenomics Laboratories, Inc. Respondent Represente
April 26, 2019	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 25, 2019 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Empl
April 26, 2019	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 22, 2019 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Empl
February 28, 2019	EX-99.1	UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Eric Q. Li Quian Diao Junior Party (Patent 7,685,077 C1), Jason Weston Isabelle Guyon, Senior Party (Application 12/994,197). (Patent Interference No. 106,066) (JTM) ( Exhibit 99.1 [email protected] Tel: 571-272-9797 Entered: February 27, 2019 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Eric Q. Li and Quian Diao Junior Party (Patent 7,685,077 C1), v. Jason Weston and Isabelle Guyon, Senior Party (Application 12/994,197). (Patent Interference No. 106,066) (JTM) (Technology Center 2100) Before SALLY GARDNER LANE, JAM
February 28, 2019	EX-99.2	UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Eric Q. Li Quian Diao Junior Party (Patent 7,685,077 C1), Jason Weston Isabelle Guyon, Senior Party (Application 12/994,197). (Patent Interference No. 106,066) (JTM) ( Exhibit 99.2 [email protected] Tel: 571-272-9797 Entered: February 27, 2019 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Eric Q. Li and Quian Diao Junior Party (Patent 7,685,077 C1), v. Jason Weston and Isabelle Guyon, Senior Party (Application 12/994,197). (Patent Interference No. 106,066) (JTM) (Technology Center 2100) Before SALLY GARDNER LANE, JAM
February 28, 2019	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 27, 2019 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
May 15, 2018	8-K	Financial Statements and Exhibits 8-K 1 tv4942658k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 9, 2018 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commis
March 23, 2018	EX-99.1	March 19, 2018 EXHIBIT 99.1 March 19, 2018 Health Discovery Corporation VIA Email I respectfully resign from my board position with Health Discovery Corporation. I wish the company good luck with it future endeavors. /s/ Kevin Kowbel, P.Eng.
March 23, 2018	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 19, 2018 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Empl
January 29, 2018	EX-16.1	16.1 – Letter from Frazier & Deeter, LLC, dated January 29, 2018, regarding Change in Certifying Accountant. EXHIBIT 16.1 January 29, 2018 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read the statements made by Health Discovery Corporation (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of Health Discovery Corporation dated January 29, 2018. We agree with the stat
January 29, 2018	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 tv4842738k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 23, 2018 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (C
December 22, 2017	8-K	Current Report 8-K 1 tv4820048k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 18, 2017 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (
October 27, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 23, 2017 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Em
May 2, 2017	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 26, 2017 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Empl
April 11, 2017	EX-99.1	April 6, 2017 EXHIBIT 99.1 April 6, 2017 George McGovern, III Chairman, Board of Directors Health Discovery Corporation VIA Email Hello George, Due to health reasons, I hereby resign as a director of Health Discovery Corporation, effective immediately. The Company has my best wishes and support going forward. /s/ William F. Quirk, Jr. cc: Health Discovery Corporation Board of Directors
April 11, 2017	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 5, 2017 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
March 2, 2017	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 24, 2017 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
January 26, 2017	EX-10.27	Health Discovery Corporation 4243 Dunwoody Club Drive, Suite 202 Atlanta, Georgia 30350 (678) 336-5300 EXHIBIT 10.27 Health Discovery Corporation 4243 Dunwoody Club Drive, Suite 202 Atlanta, Georgia 30350 (678) 336-5300 January 23, 2017 VIA EMAIL Douglas M. VanOort Chairman and Chief Executive Officer NeoGenomics Laboratories, Inc. 12701 Commonwealth Drive Suite 9 Fort Myers, Florida 33913 Mr. VanOort: Health Discovery Corporation (?HDC?) has previously requested a complete statement of any and all
January 26, 2017	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 23, 2017 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Em
November 21, 2016	10-Q	Health Discovery FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly REPORT PURSUANT to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2016 or ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY
November 14, 2016	NT 10-Q	Health Discovery NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2016 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report o
October 19, 2016	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 18, 2016 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Em
September 27, 2016	8-K	Current Report 8-K 1 t16006088k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 21, 2016 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation)
August 22, 2016	10-Q	Health Discovery FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2016 or ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY CORP
August 15, 2016	NT 10-Q	Health Discovery NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10D ? Form N-SAR ? Form N-CSR For Period Ended: June 30, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on For
May 23, 2016	10-Q	Health Discovery FORM 10-Q (Quarterly Report) 10-Q 1 t160035510q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2016 or ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission file numb
May 23, 2016	8-K	Submission of Matters to a Vote of Security Holders 8-K 1 t16003618k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 17, 2016 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commi
May 16, 2016	NT 10-Q	Health Discovery NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on F
April 14, 2016	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 13, 2016 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Empl
April 5, 2016	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 30, 2016 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Empl
March 30, 2016	10-K	Health Discovery FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ? TRANSITION REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-62216 HEALTH DISCOVERY CORPORATIO
November 16, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly REPORT PURSUANT to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2015 or ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY
November 16, 2015	10-Q	Health Discovery Form 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly REPORT PURSUANT to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2015 or ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY
August 14, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2015 or ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY CORP
June 17, 2015	EX-99.1	SVM Capital Joins Manifold Partners EXHIBIT 99.1 June 16, 2015 SVM Capital Joins Manifold Partners Manifold Partners, a San Francisco-based multi-strategy portfolio management firm specializing in quantitative investment methodologies, announced today that SVM Capital has joined as a partner. This new collaboration will be known as Manifold Vector. SVM Capital specializes in the application of an artificial intelligence technique kn
June 17, 2015	8-K	Current Report 8-K 1 t825798k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 16, 2015 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commis
May 15, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY COR
March 31, 2015	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR o TRANSITION REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-62216 HEALTH DISCOVERY CORPORATIO
February 27, 2015	8-K	Current Report 8-K 1 t816188k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 27, 2015 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Co
December 29, 2014	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 19, 2014 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
December 29, 2014	EX-16.1	Hancock Askew & Co., LLP 100 Riverview Drive Savannah, Georgia 31404 EXHIBIT 16.1 Hancock Askew & Co., LLP 100 Riverview Drive Savannah, Georgia 31404 December 29, 2014 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of the Form 8-K dated December 29, 2014, of Health Discovery Corporation and are in agreement with the statements contained therein. /s/ Hancock Askew & Co., LLP Savannah, Georgia
December 29, 2014	EX-16.1	Hancock Askew & Co., LLP 100 Riverview Drive Savannah, Georgia 31404 EXHIBIT 16.1 Hancock Askew & Co., LLP 100 Riverview Drive Savannah, Georgia 31404 December 29, 2014 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of the Form 8-K dated December 29, 2014, of Health Discovery Corporation and are in agreement with the statements contained therein. /s/ Hancock Askew & Co., LLP Savannah, Georgia
December 29, 2014	EX-16.1	Hancock Askew & Co., LLP 100 Riverview Drive Savannah, Georgia 31404 EXHIBIT 16.1 Hancock Askew & Co., LLP 100 Riverview Drive Savannah, Georgia 31404 December 29, 2014 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of the Form 8-K dated December 29, 2014, of Health Discovery Corporation and are in agreement with the statements contained therein. /s/ Hancock Askew & Co., LLP Savannah, Georgia
November 14, 2014	EX-3.1D	AMENDED AND RESTATED ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF HEALTH DISCOVERY EXHIBIT 3.1 (d) AMENDED AND RESTATED ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF HEALTH DISCOVERY CORPORATION 1. The name of the corporation is Health Discovery Corporation. 2. The Articles of Incorporation of Health Discovery Corporation are hereby amended to insert a new Section 2C ? Series C Preferred Stock, as follows: Section 2C. Series C Preferred Stock 1. Designation. The shares o
November 14, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY
November 14, 2014	EX-3.1D	AMENDED AND RESTATED ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF HEALTH DISCOVERY EXHIBIT 3.1 (d) AMENDED AND RESTATED ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF HEALTH DISCOVERY CORPORATION 1. The name of the corporation is Health Discovery Corporation. 2. The Articles of Incorporation of Health Discovery Corporation are hereby amended to insert a new Section 2C ? Series C Preferred Stock, as follows: Section 2C. Series C Preferred Stock 1. Designation. The shares o
November 14, 2014	EX-3.1D	AMENDED AND RESTATED ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF HEALTH DISCOVERY EXHIBIT 3.1 (d) AMENDED AND RESTATED ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF HEALTH DISCOVERY CORPORATION 1. The name of the corporation is Health Discovery Corporation. 2. The Articles of Incorporation of Health Discovery Corporation are hereby amended to insert a new Section 2C ? Series C Preferred Stock, as follows: Section 2C. Series C Preferred Stock 1. Designation. The shares o
August 14, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY CORP
May 15, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY COR
March 31, 2014	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K 10-K 1 t7873010k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR o TRANSITION REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-62
November 12, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 or o TRANSITION REPORT PURSU UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY
October 25, 2013	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 21, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Em
October 17, 2013	EX-99.1	Norris, Takeichi, Mineta EXHIBIT 99.1 Norris, Takeichi, Mineta October 14, 2013 Mr. Kevin Kowbel Acting CEO Health Discovery Corporation, Inc. Atlanta, GA 30350 Re: Letter of Joint Resignation from HDC’s Board of Directors Mr. Kowbel – We hereby give formal written notice to Health Discovery Corporation, Inc. (HDC) that, unless and until the SEC, or other appropriate government officials, reinstate us as Board Members at
October 17, 2013	8-K	Financial Statements and Exhibits 8-K 1 t775998k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 11, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Com
August 14, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY CORP
August 6, 2013	EX-10.1	Health Discovery Corporation 4243 Dunwoody Club Drive Suite 202 Atlanta, Georgia 30340 EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 Health Discovery Corporation 4243 Dunwoody Club Drive Suite 202 Atlanta, Georgia 30340 August 6, 2013 Dear Fellow Owners of Health Discovery Corporation, On behalf of the majority of Health Discovery Corporation’s Board of Directors (the “Board”), I want update you on the recent changes at Health Discovery Corporation (“HDC” or “Company”) so you might
August 6, 2013	EX-10.1	Health Discovery Corporation 4243 Dunwoody Club Drive Suite 202 Atlanta, Georgia 30340 EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 Health Discovery Corporation 4243 Dunwoody Club Drive Suite 202 Atlanta, Georgia 30340 August 6, 2013 Dear Fellow Owners of Health Discovery Corporation, On behalf of the majority of Health Discovery Corporation’s Board of Directors (the “Board”), I want update you on the recent changes at Health Discovery Corporation (“HDC” or “Company”) so you might
August 6, 2013	8-K	Financial Statements and Exhibits 8-K 1 t771078k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 31, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commis
August 6, 2013	EX-10.1	Health Discovery Corporation 4243 Dunwoody Club Drive Suite 202 Atlanta, Georgia 30340 EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 Health Discovery Corporation 4243 Dunwoody Club Drive Suite 202 Atlanta, Georgia 30340 August 6, 2013 Dear Fellow Owners of Health Discovery Corporation, On behalf of the majority of Health Discovery Corporation’s Board of Directors (the “Board”), I want update you on the recent changes at Health Discovery Corporation (“HDC” or “Company”) so you might
August 2, 2013	8-K	Financial Statements and Exhibits 8-K 1 t770768k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commis
July 31, 2013	8-K	Submission of Matters to a Vote of Security Holders 8-K 1 t770628k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 25, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commis
July 24, 2013	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 24, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
July 19, 2013	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K / A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K / A (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR o TRANSITION REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-62216 HEALTH DISCOVERY CORPOR
July 19, 2013	8-K	Financial Statements and Exhibits 8-K 1 t769798k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 19, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commis
July 3, 2013	8-K	Financial Statements and Exhibits 8-K 1 t768888k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 3, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commiss
June 18, 2013	8-K	Current Report 8-K 1 t768018k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 12, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commis
May 30, 2013	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 23, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employ
May 17, 2013	EX-99.1	Health Discovery Corporation 620 County Road Hanson, Massachusetts 02341 EXHIBIT 99.1 Health Discovery Corporation 620 County Road Hanson, Massachusetts 02341 May 17, 2013 Dear Fellow Shareholders, We, the Senior Management Team, with the input and majority support of HDC’s Board, want to take the time occasionally, as appropriate, to write to you regarding an update to the Health Discovery Corporation (“HDC” or “Company”) business story, including a few details of som
May 17, 2013	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 17, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employ
May 15, 2013	EX-10.28	NON-QUALIFIED STOCK OPTION AWARD OF HEALTH DISCOVERY CORPORATION EX-10.28 2 ex10-28.htm EXHIBIT 10.28 EXHIBIT 10.28 NON-QUALIFIED STOCK OPTION AWARD OF HEALTH DISCOVERY CORPORATION THIS NON-QUALIFIED STOCK OPTION AWARD (the “Award”) is made as of the Grant Date by HEALTH DISCOVERY CORPORATION, a corporation organized under the laws of the State of Georgia (the “Company”) to (the “Optionee”). Upon and subject to the Terms and Conditions attached hereto and incor
May 15, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY COR
March 29, 2013	EX-10.12	EMPLOYMENT AGREEMENT EX-10.12 2 ex10-12.htm EXHIBIT 10.12 EXHIBIT 10.12 EMPLOYMENT AGREEMENT THIS AGREEMENT (the “Agreement”) to be effective as of December 18, 2012 (the “Effective Date”), between Health Discovery Corporation (the “Company”), and John Norris (the “Executive”). INTRODUCTION The Company and the Executive are parties to an employment agreement dated September, 2009, which has expired, and now desire to
March 29, 2013	EX-10.12	EMPLOYMENT AGREEMENT EX-10.12 2 ex10-12.htm EXHIBIT 10.12 EXHIBIT 10.12 EMPLOYMENT AGREEMENT THIS AGREEMENT (the “Agreement”) to be effective as of December 18, 2012 (the “Effective Date”), between Health Discovery Corporation (the “Company”), and John Norris (the “Executive”). INTRODUCTION The Company and the Executive are parties to an employment agreement dated September, 2009, which has expired, and now desire to
March 29, 2013	EX-10.13	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.13 3 ex10-13.htm EXHIBIT 10.13 Exhibit 10.13 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 January 31, 2013 Stephen D. Barnhill, M.D. Re: Termination of Consulting Agreement Dear Steve: The purpose of this letter is to notify you that effective January 31, 2013 (the “Termination Date”) Health Discovery Corporation (the “Company”) has terminated the Cons
March 29, 2013	EX-10.13	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.13 3 ex10-13.htm EXHIBIT 10.13 Exhibit 10.13 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 January 31, 2013 Stephen D. Barnhill, M.D. Re: Termination of Consulting Agreement Dear Steve: The purpose of this letter is to notify you that effective January 31, 2013 (the “Termination Date”) Health Discovery Corporation (the “Company”) has terminated the Cons
March 29, 2013	EX-10.13	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.13 3 ex10-13.htm EXHIBIT 10.13 Exhibit 10.13 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 January 31, 2013 Stephen D. Barnhill, M.D. Re: Termination of Consulting Agreement Dear Steve: The purpose of this letter is to notify you that effective January 31, 2013 (the “Termination Date”) Health Discovery Corporation (the “Company”) has terminated the Cons
March 29, 2013	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR o TRANSITION REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-62216 HEALTH DISCOVERY CORPORATIO
March 29, 2013	EX-10.13	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.13 3 ex10-13.htm EXHIBIT 10.13 Exhibit 10.13 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 January 31, 2013 Stephen D. Barnhill, M.D. Re: Termination of Consulting Agreement Dear Steve: The purpose of this letter is to notify you that effective January 31, 2013 (the “Termination Date”) Health Discovery Corporation (the “Company”) has terminated the Cons
March 29, 2013	EX-10.12	EMPLOYMENT AGREEMENT EX-10.12 2 ex10-12.htm EXHIBIT 10.12 EXHIBIT 10.12 EMPLOYMENT AGREEMENT THIS AGREEMENT (the “Agreement”) to be effective as of December 18, 2012 (the “Effective Date”), between Health Discovery Corporation (the “Company”), and John Norris (the “Executive”). INTRODUCTION The Company and the Executive are parties to an employment agreement dated September, 2009, which has expired, and now desire to
March 1, 2013	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 25, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
February 6, 2013	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 31, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Em
January 11, 2013	EX-10.1	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, GA 31401 (912) 443-1987 Exhibit 10.1 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, GA 31401 (912) 443-1987 October 21, 2012 Stephen D. Barnhill, M.D. Stephen D. Barnhill, MD and Associates, LLC Re: Consulting Agreement The following letter shall constitute the definitive agreement between you (the "Consultant"), as a representative of Stephen D. Barnhill, MD and Associates, LLC, and Health Discov
January 11, 2013	EX-10.1	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, GA 31401 (912) 443-1987 Exhibit 10.1 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, GA 31401 (912) 443-1987 October 21, 2012 Stephen D. Barnhill, M.D. Stephen D. Barnhill, MD and Associates, LLC Re: Consulting Agreement The following letter shall constitute the definitive agreement between you (the "Consultant"), as a representative of Stephen D. Barnhill, MD and Associates, LLC, and Health Discov
January 11, 2013	8-K	- FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 7, 2013 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emp
January 11, 2013	EX-10.2	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.2 3 ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 January 7, 2013 Stephen D. Barnhill, M.D. Stephen D. Barnhill, M.D. and Associates, LLC Re: Consulting Agreement Dear Steve: The purpose of this letter is to notify you that Health Discovery Corporation (the “Company) is terminating the Consulting Agreement entered in
January 11, 2013	EX-10.2	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.2 3 ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 January 7, 2013 Stephen D. Barnhill, M.D. Stephen D. Barnhill, M.D. and Associates, LLC Re: Consulting Agreement Dear Steve: The purpose of this letter is to notify you that Health Discovery Corporation (the “Company) is terminating the Consulting Agreement entered in
January 11, 2013	EX-10.2	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.2 3 ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 January 7, 2013 Stephen D. Barnhill, M.D. Stephen D. Barnhill, M.D. and Associates, LLC Re: Consulting Agreement Dear Steve: The purpose of this letter is to notify you that Health Discovery Corporation (the “Company) is terminating the Consulting Agreement entered in
December 27, 2012	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 18, 2012 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
December 10, 2012	8-K	Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 6, 2012 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Em
November 29, 2012	8-K	Financial Statements and Exhibits 8-K 1 t751018k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 25, 2012 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Co
November 29, 2012	EX-99.1	November 25, 2012 EXHIBIT 99.1 November 25, 2012 Joseph McKenzie, D.V.M Chairman, Board of Directors Health Discovery Corporation VIA Email Joe, This will be my official notice of my resignation from the board of Health Discovery Corporation effective Monday Nov. 26, 2012. Sincerely, /s/ Curtis G. Anderson Curtis G. Anderson
November 21, 2012	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 15, 2012 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
November 16, 2012	EX-10.2	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EXHIBIT 10.2 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 September 28, 2012 Stafford O?Kelly Abbott Molecular VIA Email Stafford, Health Discovery Corporation has received your notice that Abbott Molecular is not interested in moving forward with the Prostate Cancer License and Development Agreements. It is our understanding that this results in a terminati
November 16, 2012	EX-10.1	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 October 21, 2012 Stephen D. Barnhill, M.D. Stephen D. Barnhill, MD and Associates, LLC 2 Springfield Place Savannah, GA 31411 Re: Consulting Agreement Dear Steve: The following letter shall constitute the definitive agreement between you (the “Consultant”), as a repre
November 16, 2012	EX-10.2	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EXHIBIT 10.2 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 September 28, 2012 Stafford O?Kelly Abbott Molecular VIA Email Stafford, Health Discovery Corporation has received your notice that Abbott Molecular is not interested in moving forward with the Prostate Cancer License and Development Agreements. It is our understanding that this results in a terminati
November 16, 2012	EX-10.1	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 October 21, 2012 Stephen D. Barnhill, M.D. Stephen D. Barnhill, MD and Associates, LLC 2 Springfield Place Savannah, GA 31411 Re: Consulting Agreement Dear Steve: The following letter shall constitute the definitive agreement between you (the “Consultant”), as a repre
November 16, 2012	EX-10.1	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 October 21, 2012 Stephen D. Barnhill, M.D. Stephen D. Barnhill, MD and Associates, LLC 2 Springfield Place Savannah, GA 31411 Re: Consulting Agreement Dear Steve: The following letter shall constitute the definitive agreement between you (the “Consultant”), as a repre
November 16, 2012	EX-10.2	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EXHIBIT 10.2 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 September 28, 2012 Stafford O?Kelly Abbott Molecular VIA Email Stafford, Health Discovery Corporation has received your notice that Abbott Molecular is not interested in moving forward with the Prostate Cancer License and Development Agreements. It is our understanding that this results in a terminati
November 16, 2012	EX-10.1	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 October 21, 2012 Stephen D. Barnhill, M.D. Stephen D. Barnhill, MD and Associates, LLC 2 Springfield Place Savannah, GA 31411 Re: Consulting Agreement Dear Steve: The following letter shall constitute the definitive agreement between you (the “Consultant”), as a repre
November 16, 2012	EX-10.1	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 October 21, 2012 Stephen D. Barnhill, M.D. Stephen D. Barnhill, MD and Associates, LLC 2 Springfield Place Savannah, GA 31411 Re: Consulting Agreement Dear Steve: The following letter shall constitute the definitive agreement between you (the “Consultant”), as a repre
November 16, 2012	EX-10.2	Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 EXHIBIT 10.2 Health Discovery Corporation 2 East Bryan Street, Suite 1500 Savannah, Georgia 31401 September 28, 2012 Stafford O?Kelly Abbott Molecular VIA Email Stafford, Health Discovery Corporation has received your notice that Abbott Molecular is not interested in moving forward with the Prostate Cancer License and Development Agreements. It is our understanding that this results in a terminati
November 16, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 or o TRANSITION REPORT PURSU 10-Q 1 t7498910q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file nu
November 15, 2012	NT 10-Q	- FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report
October 25, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 21, 2012 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Em
August 14, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY CORP
July 6, 2012	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 29, 2012 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
May 15, 2012	EX-10.1	EMPLOYMENT AGREEMENT EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EMPLOYMENT AGREEMENT Exhibit 10.1 THIS AGREEMENT (the “Agreement”) to be effective as of May 14, 2012(the “Effective Date”), between Health Discovery Corporation (the “Company”), and Stephen Barnhill (the “Executive”). INTRODUCTION The Company and the Executive are parties to an employment agreement dated September 15, 2008, which has expired, and now desire to en
May 15, 2012	EX-10.1	EMPLOYMENT AGREEMENT EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EMPLOYMENT AGREEMENT Exhibit 10.1 THIS AGREEMENT (the “Agreement”) to be effective as of May 14, 2012(the “Effective Date”), between Health Discovery Corporation (the “Company”), and Stephen Barnhill (the “Executive”). INTRODUCTION The Company and the Executive are parties to an employment agreement dated September 15, 2008, which has expired, and now desire to en
May 15, 2012	EX-10.1	EMPLOYMENT AGREEMENT EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EMPLOYMENT AGREEMENT Exhibit 10.1 THIS AGREEMENT (the “Agreement”) to be effective as of May 14, 2012(the “Effective Date”), between Health Discovery Corporation (the “Company”), and Stephen Barnhill (the “Executive”). INTRODUCTION The Company and the Executive are parties to an employment agreement dated September 15, 2008, which has expired, and now desire to en
May 15, 2012	EX-10.1	EMPLOYMENT AGREEMENT EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EMPLOYMENT AGREEMENT Exhibit 10.1 THIS AGREEMENT (the “Agreement”) to be effective as of May 14, 2012(the “Effective Date”), between Health Discovery Corporation (the “Company”), and Stephen Barnhill (the “Executive”). INTRODUCTION The Company and the Executive are parties to an employment agreement dated September 15, 2008, which has expired, and now desire to en
May 15, 2012	EX-10.1	EMPLOYMENT AGREEMENT EX-10.1 2 ex10-1.htm EXHIBIT 10.1 EMPLOYMENT AGREEMENT Exhibit 10.1 THIS AGREEMENT (the “Agreement”) to be effective as of May 14, 2012(the “Effective Date”), between Health Discovery Corporation (the “Company”), and Stephen Barnhill (the “Executive”). INTRODUCTION The Company and the Executive are parties to an employment agreement dated September 15, 2008, which has expired, and now desire to en
May 15, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q V6-R x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVER
March 30, 2012	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR o TRANSITION REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-62216 HEALTH DISCOVERY CORPORATIO
January 12, 2012	EX-10.27	License Agreement, dated January 6, 2012, between Health Discovery Corporation and NeoGenomics Laboratories, Inc. Registrant incorporates by reference Exhibit 10.27 to Form 8-K filed on January 12, 2012. EX-10.27 2 ex10-27.htm EXHIBIT 10.27 Exhibit 10.27 MASTER LICENSE AGREEMENT THIS LICENSE AGREEMENT dated as of January 6, 2012 (this “Agreement”), is entered into among and between HEALTH DISCOVERY CORPORATION, a Georgia corporation ("LICENSOR") having a place of business at 2 East Bryan Street, Suite 1500, Savannah, GA 31401, and NEOGENOMICS LABORATORIES, INC. a Florida corporation (“LICENSEE”),
January 12, 2012	EX-10.27	License Agreement, dated January 6, 2012, between Health Discovery Corporation and NeoGenomics Laboratories, Inc. Registrant incorporates by reference Exhibit 10.27 to Form 8-K filed on January 12, 2012. EX-10.27 2 ex10-27.htm EXHIBIT 10.27 Exhibit 10.27 MASTER LICENSE AGREEMENT THIS LICENSE AGREEMENT dated as of January 6, 2012 (this “Agreement”), is entered into among and between HEALTH DISCOVERY CORPORATION, a Georgia corporation ("LICENSOR") having a place of business at 2 East Bryan Street, Suite 1500, Savannah, GA 31401, and NEOGENOMICS LABORATORIES, INC. a Florida corporation (“LICENSEE”),
January 12, 2012	EX-10.27	License Agreement, dated January 6, 2012, between Health Discovery Corporation and NeoGenomics Laboratories, Inc. Registrant incorporates by reference Exhibit 10.27 to Form 8-K filed on January 12, 2012. EX-10.27 2 ex10-27.htm EXHIBIT 10.27 Exhibit 10.27 MASTER LICENSE AGREEMENT THIS LICENSE AGREEMENT dated as of January 6, 2012 (this “Agreement”), is entered into among and between HEALTH DISCOVERY CORPORATION, a Georgia corporation ("LICENSOR") having a place of business at 2 East Bryan Street, Suite 1500, Savannah, GA 31401, and NEOGENOMICS LABORATORIES, INC. a Florida corporation (“LICENSEE”),
January 12, 2012	EX-99.1	Health Discovery Corporation Enters Into Worldwide Licensing Agreement With NeoGenomics License is for Hematopoietic and Solid Tumor Cancers EXHIBIT 99.1 Health Discovery Corporation Enters Into Worldwide Licensing Agreement With NeoGenomics License is for Hematopoietic and Solid Tumor Cancers SAVANNAH, Ga. - January 9, 2012 – Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, has entered into an exclusive worldwide licens
January 12, 2012	EX-10.27	License Agreement, dated January 6, 2012, between Health Discovery Corporation and NeoGenomics Laboratories, Inc. Registrant incorporates by reference Exhibit 10.27 to Form 8-K filed on January 12, 2012. EX-10.27 2 ex10-27.htm EXHIBIT 10.27 Exhibit 10.27 MASTER LICENSE AGREEMENT THIS LICENSE AGREEMENT dated as of January 6, 2012 (this “Agreement”), is entered into among and between HEALTH DISCOVERY CORPORATION, a Georgia corporation ("LICENSOR") having a place of business at 2 East Bryan Street, Suite 1500, Savannah, GA 31401, and NEOGENOMICS LABORATORIES, INC. a Florida corporation (“LICENSEE”),
January 12, 2012	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 6, 2012 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emp
January 12, 2012	EX-10.27	License Agreement, dated January 6, 2012, between Health Discovery Corporation and NeoGenomics Laboratories, Inc. Registrant incorporates by reference Exhibit 10.27 to Form 8-K filed on January 12, 2012. EX-10.27 2 ex10-27.htm EXHIBIT 10.27 Exhibit 10.27 MASTER LICENSE AGREEMENT THIS LICENSE AGREEMENT dated as of January 6, 2012 (this “Agreement”), is entered into among and between HEALTH DISCOVERY CORPORATION, a Georgia corporation ("LICENSOR") having a place of business at 2 East Bryan Street, Suite 1500, Savannah, GA 31401, and NEOGENOMICS LABORATORIES, INC. a Florida corporation (“LICENSEE”),
November 14, 2011	EX-10.26	FIRST AMENDMENT TO THE LICENSE AGREEMENT EX-10.26 2 ex10-26.htm EXHIBIT 10.26 Exhibit 10.26 FIRST AMENDMENT TO THE LICENSE AGREEMENT This First Amendment to the License Agreement (“First Amendment”) is entered into, and made effective on, August 4, 2011 by and between Health Discovery Corporation, a Georgia corporation (“HDC”), having its principal place of business at 2 East Bryan Street, Suite #610, Savannah, GA 31401 (“HDC”), and Abbo
November 14, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 t7193410q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file nu
November 14, 2011	EX-10.26	FIRST AMENDMENT TO THE LICENSE AGREEMENT EX-10.26 2 ex10-26.htm EXHIBIT 10.26 Exhibit 10.26 FIRST AMENDMENT TO THE LICENSE AGREEMENT This First Amendment to the License Agreement (“First Amendment”) is entered into, and made effective on, August 4, 2011 by and between Health Discovery Corporation, a Georgia corporation (“HDC”), having its principal place of business at 2 East Bryan Street, Suite #610, Savannah, GA 31401 (“HDC”), and Abbo
November 14, 2011	EX-10.26	FIRST AMENDMENT TO THE LICENSE AGREEMENT EX-10.26 2 ex10-26.htm EXHIBIT 10.26 Exhibit 10.26 FIRST AMENDMENT TO THE LICENSE AGREEMENT This First Amendment to the License Agreement (“First Amendment”) is entered into, and made effective on, August 4, 2011 by and between Health Discovery Corporation, a Georgia corporation (“HDC”), having its principal place of business at 2 East Bryan Street, Suite #610, Savannah, GA 31401 (“HDC”), and Abbo
November 14, 2011	EX-10.26	FIRST AMENDMENT TO THE LICENSE AGREEMENT EX-10.26 2 ex10-26.htm EXHIBIT 10.26 Exhibit 10.26 FIRST AMENDMENT TO THE LICENSE AGREEMENT This First Amendment to the License Agreement (“First Amendment”) is entered into, and made effective on, August 4, 2011 by and between Health Discovery Corporation, a Georgia corporation (“HDC”), having its principal place of business at 2 East Bryan Street, Suite #610, Savannah, GA 31401 (“HDC”), and Abbo
August 15, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY CORP
August 15, 2011	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 10, 2011 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emp
August 4, 2011	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2011 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
May 18, 2011	424B3	Prospectus Supplement Filed Under Rule 424(b)(3) Registration No. 333-171120 Prospectus Supplement No. 1 dated May 18, 2011 (to Prospectus dated April 15, 2011) HEALTH DISCOVERY CORPORATION 17,875,000 Shares of Common Stock to be issued upon exercise Prospectus Supplement Filed Under Rule 424(b)(3) Registration No. 333-171120 ******************************* Prospectus Supplement No. 1 dated May 18, 2011 (to Prospectus dated April 15, 2011) HEALTH DISCOVERY CORPORATION 17,875,000 Shares of Common Stock to be issued upon exercise of Warrants 16,263,888 Shares of Common Stock This prospectus supplement to the prospectus dated April 15, 2011 relat
May 16, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2011 or o TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY COR
May 6, 2011	CORRESP	Health Discovery Corporation 2 East Bryan Street, Suite 610 Savannah, Georgia 31401 Health Discovery Corporation 2 East Bryan Street, Suite 610 Savannah, Georgia 31401 VIA EDGAR May 6, 2011 U.
May 5, 2011	S-8	As filed with the Securities and Exchange Commission on May 5, 2011 As filed with the Securities and Exchange Commission on May 5, 2011 Registration No.
May 5, 2011	EX-24.2	Consent of Independent Registered Public Accounting Firm Exhibit 24.2 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement on Form S-8, pertaining to the Health Discovery Corporation Gallager Option Agreement to be filed on or about May 5, 2011, of our report dated March 29, 2011 relating to our audit of the financial statements as of and for the year ended December 31, 2010
May 5, 2011	EX-24.2	Consent of Independent Registered Public Accounting Firm Exhibit 24.2 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement on Form S-8, pertaining to the Health Discovery Corporation Gallager Option Agreement to be filed on or about May 5, 2011, of our report dated March 29, 2011 relating to our audit of the financial statements as of and for the year ended December 31, 2010
May 5, 2011	EX-24.2	Consent of Independent Registered Public Accounting Firm Exhibit 24.2 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement on Form S-8, pertaining to the Health Discovery Corporation Gallager Option Agreement to be filed on or about May 5, 2011, of our report dated March 29, 2011 relating to our audit of the financial statements as of and for the year ended December 31, 2010
May 5, 2011	EX-24.2	Consent of Independent Registered Public Accounting Firm Exhibit 24.2 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement on Form S-8, pertaining to the Health Discovery Corporation Gallager Option Agreement to be filed on or about May 5, 2011, of our report dated March 29, 2011 relating to our audit of the financial statements as of and for the year ended December 31, 2010
May 5, 2011	EX-24.2	Consent of Independent Registered Public Accounting Firm Exhibit 24.2 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement on Form S-8, pertaining to the Health Discovery Corporation Gallager Option Agreement to be filed on or about May 5, 2011, of our report dated March 29, 2011 relating to our audit of the financial statements as of and for the year ended December 31, 2010
April 15, 2011	S-1/A	As filed with the Securities and Exchange Commission on April 15, 2011 As filed with the Securities and Exchange Commission on April 15, 2011 Registration No.
April 15, 2011	CORRESP	April 15, 2011 Arnold M. Zipper Direct Dial: 954-703-3931 Direct Fax: 954-707-4549 [email protected] April 15, 2011 VIA EDGAR AND FACSIMILE (703-813-6981) Mr. Mark P. Shuman Branch Chief United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Health Discovery Corporation Amendment No. 1 to Registration Statement on Form S-1 Filed December 10, 2010 File No. 333-1
April 13, 2011	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 7, 2011 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
March 31, 2011	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 OR o TRANSITION REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-62216 HEALTH DISCOVERY CORPORATION
March 31, 2011	EX-10.25	Health Discovery Corporation 2 East Bryan Street Suite 610 Savannah, Georgia 31401 EX-10.25 2 ex10-25.htm EXHIBIT 10.25 Exhibit 10.25 Health Discovery Corporation 2 East Bryan Street Suite 610 Savannah, Georgia 31401 March 28, 2011 Stephen D. Barnhill, M.D. 2 Springfield Place Savannah, Georgia 31411 RE: Month-to-Month Extension of Employment Agreement Dear Dr. Barnhill: Reference is made to your Employment Agreement dated as of August 15, 2008 (the “Agreement”). As you are awar
March 31, 2011	EX-10.25	Health Discovery Corporation 2 East Bryan Street Suite 610 Savannah, Georgia 31401 EX-10.25 2 ex10-25.htm EXHIBIT 10.25 Exhibit 10.25 Health Discovery Corporation 2 East Bryan Street Suite 610 Savannah, Georgia 31401 March 28, 2011 Stephen D. Barnhill, M.D. 2 Springfield Place Savannah, Georgia 31411 RE: Month-to-Month Extension of Employment Agreement Dear Dr. Barnhill: Reference is made to your Employment Agreement dated as of August 15, 2008 (the “Agreement”). As you are awar
March 31, 2011	EX-10.25	Health Discovery Corporation 2 East Bryan Street Suite 610 Savannah, Georgia 31401 EX-10.25 2 ex10-25.htm EXHIBIT 10.25 Exhibit 10.25 Health Discovery Corporation 2 East Bryan Street Suite 610 Savannah, Georgia 31401 March 28, 2011 Stephen D. Barnhill, M.D. 2 Springfield Place Savannah, Georgia 31411 RE: Month-to-Month Extension of Employment Agreement Dear Dr. Barnhill: Reference is made to your Employment Agreement dated as of August 15, 2008 (the “Agreement”). As you are awar
March 31, 2011	EX-10.25	Health Discovery Corporation 2 East Bryan Street Suite 610 Savannah, Georgia 31401 EX-10.25 2 ex10-25.htm EXHIBIT 10.25 Exhibit 10.25 Health Discovery Corporation 2 East Bryan Street Suite 610 Savannah, Georgia 31401 March 28, 2011 Stephen D. Barnhill, M.D. 2 Springfield Place Savannah, Georgia 31411 RE: Month-to-Month Extension of Employment Agreement Dear Dr. Barnhill: Reference is made to your Employment Agreement dated as of August 15, 2008 (the “Agreement”). As you are awar
March 31, 2011	EX-10.25	Health Discovery Corporation 2 East Bryan Street Suite 610 Savannah, Georgia 31401 EX-10.25 2 ex10-25.htm EXHIBIT 10.25 Exhibit 10.25 Health Discovery Corporation 2 East Bryan Street Suite 610 Savannah, Georgia 31401 March 28, 2011 Stephen D. Barnhill, M.D. 2 Springfield Place Savannah, Georgia 31411 RE: Month-to-Month Extension of Employment Agreement Dear Dr. Barnhill: Reference is made to your Employment Agreement dated as of August 15, 2008 (the “Agreement”). As you are awar
March 31, 2011	EX-99.1	2010 ANNUAL MEETING OF SHAREHOLDERS NOTICE OF ANNUAL MEETING AND PROXY STATEMENT TABLE OF CONTENTS Exhibit 99.1 HEALTH DISCOVERY CORPORATION 2 East Bryan Street, 5th Floor Savannah, Georgia 31401 Phone (912) 443-1987 September 24, 2010 Dear Shareholder: I invite you to attend our Annual Meeting of Shareholders, which will be held on Thursday, October 21, 2010, at 10:00 a.m. at the AVIA Savannah Hotel, Parlor A, 14 Barnard Street, Savannah, Georgia 31401. Details regarding the business to be con
February 28, 2011	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 22, 2011 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
February 15, 2011	SC 13G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) HEALTH DISCOVERY CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) (CUSIP Number) F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) HEALTH DISCOVERY CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 42218R-10-0 - (CUSIP Number) Feb. 14, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t
February 11, 2011	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2010 o Transition report under Section 13 or 15(d) of the Exchange Act For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY CORPORATION (Exact name of regi
February 11, 2011	EX-10.1	SETTLEMENT AND RELEASE AGREEMENT Exhibit 10.1 SETTLEMENT AND RELEASE AGREEMENT THIS SETTLEMENT AND RELEASE AGREEMENT (together with the exhibits hereto, the ?Settlement Agreement?) is made and entered into on the July 27, 2010 by and between Health Discovery Corporation (?HDC?) and Prime Mover Capital Partners, LP (the ?Investor?) (HDC and Investor are collectively referred to herein as the ?Parties?). W I T N E S S E T H: WHEREA
February 11, 2011	EX-10.1	SETTLEMENT AND RELEASE AGREEMENT Exhibit 10.1 SETTLEMENT AND RELEASE AGREEMENT THIS SETTLEMENT AND RELEASE AGREEMENT (together with the exhibits hereto, the ?Settlement Agreement?) is made and entered into on the July 27, 2010 by and between Health Discovery Corporation (?HDC?) and Prime Mover Capital Partners, LP (the ?Investor?) (HDC and Investor are collectively referred to herein as the ?Parties?). W I T N E S S E T H: WHEREA
February 11, 2011	EX-10.1	SETTLEMENT AND RELEASE AGREEMENT Exhibit 10.1 SETTLEMENT AND RELEASE AGREEMENT THIS SETTLEMENT AND RELEASE AGREEMENT (together with the exhibits hereto, the ?Settlement Agreement?) is made and entered into on the July 27, 2010 by and between Health Discovery Corporation (?HDC?) and Prime Mover Capital Partners, LP (the ?Investor?) (HDC and Investor are collectively referred to herein as the ?Parties?). W I T N E S S E T H: WHEREA
February 11, 2011	EX-10.1	SETTLEMENT AND RELEASE AGREEMENT Exhibit 10.1 SETTLEMENT AND RELEASE AGREEMENT THIS SETTLEMENT AND RELEASE AGREEMENT (together with the exhibits hereto, the ?Settlement Agreement?) is made and entered into on the July 27, 2010 by and between Health Discovery Corporation (?HDC?) and Prime Mover Capital Partners, LP (the ?Investor?) (HDC and Investor are collectively referred to herein as the ?Parties?). W I T N E S S E T H: WHEREA
February 11, 2011	EX-10.1	SETTLEMENT AND RELEASE AGREEMENT Exhibit 10.1 SETTLEMENT AND RELEASE AGREEMENT THIS SETTLEMENT AND RELEASE AGREEMENT (together with the exhibits hereto, the ?Settlement Agreement?) is made and entered into on the July 27, 2010 by and between Health Discovery Corporation (?HDC?) and Prime Mover Capital Partners, LP (the ?Investor?) (HDC and Investor are collectively referred to herein as the ?Parties?). W I T N E S S E T H: WHEREA
January 6, 2011	LETTER	LETTER January 6, 2011 Stephen D. Barnhill, M.D. Chief Executive Officer Health Discovery Corporation 2 East Bryan Street, Suite 502 Savannah, GA 31401 Re: Health Discovery Corporation Registration Statement on Form S-1 Filed December 10, 2010 File No. 333-171120 Dear Mr. Barnhill: We have limited our review of your registration statement to those issues we have addressed in our comments. In some of our
January 5, 2011	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 30, 2010 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
December 30, 2010	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 24, 2010 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
December 10, 2010	EX-10.24	RELEASE AGREEMENT Exhibit 10.24 RELEASE AGREEMENT This Agreement (this ?Agreement?) is made this 2nd day of October, 2010, by Health Discovery Corporation (?HDC?) and R. Scott Tobin (?Mr. Tobin?). Introduction Mr. Tobin and HDC entered into an Employment Agreement effective April 15, 2009 (the ?Employment Agreement?). This Agreement requires that as a condition to HDC?s obligation to pay payments and benefits under
December 10, 2010	EX-10.24	RELEASE AGREEMENT Exhibit 10.24 RELEASE AGREEMENT This Agreement (this ?Agreement?) is made this 2nd day of October, 2010, by Health Discovery Corporation (?HDC?) and R. Scott Tobin (?Mr. Tobin?). Introduction Mr. Tobin and HDC entered into an Employment Agreement effective April 15, 2009 (the ?Employment Agreement?). This Agreement requires that as a condition to HDC?s obligation to pay payments and benefits under
December 10, 2010	EX-10.24	RELEASE AGREEMENT Exhibit 10.24 RELEASE AGREEMENT This Agreement (this ?Agreement?) is made this 2nd day of October, 2010, by Health Discovery Corporation (?HDC?) and R. Scott Tobin (?Mr. Tobin?). Introduction Mr. Tobin and HDC entered into an Employment Agreement effective April 15, 2009 (the ?Employment Agreement?). This Agreement requires that as a condition to HDC?s obligation to pay payments and benefits under
December 10, 2010	EX-10.24	RELEASE AGREEMENT Exhibit 10.24 RELEASE AGREEMENT This Agreement (this ?Agreement?) is made this 2nd day of October, 2010, by Health Discovery Corporation (?HDC?) and R. Scott Tobin (?Mr. Tobin?). Introduction Mr. Tobin and HDC entered into an Employment Agreement effective April 15, 2009 (the ?Employment Agreement?). This Agreement requires that as a condition to HDC?s obligation to pay payments and benefits under
December 10, 2010	EX-10.24	RELEASE AGREEMENT Exhibit 10.24 RELEASE AGREEMENT This Agreement (this ?Agreement?) is made this 2nd day of October, 2010, by Health Discovery Corporation (?HDC?) and R. Scott Tobin (?Mr. Tobin?). Introduction Mr. Tobin and HDC entered into an Employment Agreement effective April 15, 2009 (the ?Employment Agreement?). This Agreement requires that as a condition to HDC?s obligation to pay payments and benefits under
December 10, 2010	S-1	As filed with the Securities and Exchange Commission on December 10, 2010 As filed with the Securities and Exchange Commission on December 10, 2010 Registration No.
December 9, 2010	S-8	As filed with the Securities and Exchange Commission on December 9, 2010 As filed with the Securities and Exchange Commission on December 9, 2010 Registration No.
November 15, 2010	EX-10.1	Confidential portions of this document have been omitted pursuant to a request for confidential treatment and filed separately with Securities and Exchange Commission SETTLEMENT AND RELEASE AGREEMENT Exhibit 10.1 Confidential portions of this document have been omitted pursuant to a request for confidential treatment and filed separately with Securities and Exchange Commission SETTLEMENT AND RELEASE AGREEMENT THIS SETTLEMENT AND RELEASE AGREEMENT (together with the exhibits hereto, the ?Settlement Agreement?) is made and entered into on the July 27, 2010 by and between Health Discovery Corpora
November 15, 2010	EX-10.1	Confidential portions of this document have been omitted pursuant to a request for confidential treatment and filed separately with Securities and Exchange Commission SETTLEMENT AND RELEASE AGREEMENT Exhibit 10.1 Confidential portions of this document have been omitted pursuant to a request for confidential treatment and filed separately with Securities and Exchange Commission SETTLEMENT AND RELEASE AGREEMENT THIS SETTLEMENT AND RELEASE AGREEMENT (together with the exhibits hereto, the ?Settlement Agreement?) is made and entered into on the July 27, 2010 by and between Health Discovery Corpora
November 15, 2010	EX-10.1	Confidential portions of this document have been omitted pursuant to a request for confidential treatment and filed separately with Securities and Exchange Commission SETTLEMENT AND RELEASE AGREEMENT Exhibit 10.1 Confidential portions of this document have been omitted pursuant to a request for confidential treatment and filed separately with Securities and Exchange Commission SETTLEMENT AND RELEASE AGREEMENT THIS SETTLEMENT AND RELEASE AGREEMENT (together with the exhibits hereto, the ?Settlement Agreement?) is made and entered into on the July 27, 2010 by and between Health Discovery Corpora
November 15, 2010	EX-10.2	SETTLEMENT AND RELEASE AGREEMENT EX-10.2 6 ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 SETTLEMENT AND RELEASE AGREEMENT THIS SETTLEMENT AND RELEASE AGREEMENT (together with the exhibits hereto, the “Settlement Agreement”) is made and entered into effective as of September 23, 2010, by and between Health Discovery Corporation (“HDC”), a Georgia corporation and William F. Quirk, Jr. (the “Investor”) (HDC and Investor are collectively refe
November 15, 2010	EX-10.1	Confidential portions of this document have been omitted pursuant to a request for confidential treatment and filed separately with Securities and Exchange Commission SETTLEMENT AND RELEASE AGREEMENT Exhibit 10.1 Confidential portions of this document have been omitted pursuant to a request for confidential treatment and filed separately with Securities and Exchange Commission SETTLEMENT AND RELEASE AGREEMENT THIS SETTLEMENT AND RELEASE AGREEMENT (together with the exhibits hereto, the ?Settlement Agreement?) is made and entered into on the July 27, 2010 by and between Health Discovery Corpora
November 15, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2010 o Transition report under Section 13 or 15(d) of the Exchange Act For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY CORPORATION (Exact name of regist
October 26, 2010	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 20, 2010 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Em
October 7, 2010	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 2, 2010 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emp
September 27, 2010	EX-99.1	Health Discovery Corporation Announces Results of Warrant Conversion and Settlement of the Shareholder Lawsuit Exhibit 99.1 Health Discovery Corporation Announces Results of Warrant Conversion and Settlement of the Shareholder Lawsuit SAVANNAH, Ga. ? September 27, 2010 - Health Discovery Corporation (OTCBB: HDVY) is pleased to announce the results of the warrant conversion related to the 2007 private placement (?2007 Private Placement?), as follows: 10,952,261 warrants out of a total of 57,677,707 remainin
September 27, 2010	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 23, 2010 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS
September 8, 2010	8-K	Entry into a Material Definitive Agreement, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 1, 2010 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS E
August 16, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 t6870310q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2010 o Transition report under Section 13 or 15(d) of the Exchange Act For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY CORPORA
August 2, 2010	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 27, 2010 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
July 19, 2010	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 13, 2010 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Emplo
May 25, 2010	EX-22.1	Consent of Independent Registered Public Accounting Firm Exhibit 23.1 Consent of Independent Registered Public Accounting Firm Health Discovery Corporation Savannah, Georgia We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated March 30, 2010 relating to the financial statements of Health Discovery Corporation which is contained in that Prospectus. We also consent to the reference to us und
May 25, 2010	POS AM	As filed with the Securities and Exchange Commission on April 30, 2010 As filed with the Securities and Exchange Commission on April 30, 2010 Registration No.
May 25, 2010	EX-22.1	Consent of Independent Registered Public Accounting Firm Exhibit 23.1 Consent of Independent Registered Public Accounting Firm Health Discovery Corporation Savannah, Georgia We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated March 30, 2010 relating to the financial statements of Health Discovery Corporation which is contained in that Prospectus. We also consent to the reference to us und
May 25, 2010	EX-22.1	Consent of Independent Registered Public Accounting Firm Exhibit 23.1 Consent of Independent Registered Public Accounting Firm Health Discovery Corporation Savannah, Georgia We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated March 30, 2010 relating to the financial statements of Health Discovery Corporation which is contained in that Prospectus. We also consent to the reference to us und
May 25, 2010	EX-22.1	Consent of Independent Registered Public Accounting Firm Exhibit 23.1 Consent of Independent Registered Public Accounting Firm Health Discovery Corporation Savannah, Georgia We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated March 30, 2010 relating to the financial statements of Health Discovery Corporation which is contained in that Prospectus. We also consent to the reference to us und
May 25, 2010	EX-22.1	Consent of Independent Registered Public Accounting Firm Exhibit 23.1 Consent of Independent Registered Public Accounting Firm Health Discovery Corporation Savannah, Georgia We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated March 30, 2010 relating to the financial statements of Health Discovery Corporation which is contained in that Prospectus. We also consent to the reference to us und
May 17, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2010 o Transition report under Section 13 or 15(d) of the Exchange Act For the transaction period from to Commission file number 333-62216 HEALTH DISCOVERY CORPORATION (Exact name of registrant
May 13, 2010	POS AM	As filed with the Securities and Exchange Commission on April 30, 2010 As filed with the Securities and Exchange Commission on April 30, 2010 Registration No.
May 7, 2010	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 7, 2010 Health Discovery Corporation (Exact name of registrant as specified in charter) Georgia 333-62216 74-3002154 (State of incorporation) (Commission File Number) (IRS Employe
May 7, 2010	EX-99.1	Health Discovery Corporation Announces Suit by Large Shareholder Seeking Declaratory Judgment Regarding Termination Date of Warrants Held by Shareholder Exhibit 99.1 Health Discovery Corporation Announces Suit by Large Shareholder Seeking Declaratory Judgment Regarding Termination Date of Warrants Held by Shareholder SAVANNAH, Georgia - May 7, 2010 ? Health Discovery Corporation (OTCBB:HDVY) (HDC) announced today that on May 6, 2010, William F. Quirk, Jr., a shareholder of HDC, filed a declaratory judgment action in Georgia state court In the fili
May 3, 2010	POS AM	As filed with the Securities and Exchange Commission on April 30, 2010 POS AM 1 t67906posam.htm POST-EFFECTIVE AMENDMENT NO. 2 As filed with the Securities and Exchange Commission on April 30, 2010 Registration No. 333-150878 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEALTH DISCOVERY CORPORATION (Exact Name of Registrant as Specified in Its
March 31, 2010	EX-10.7(A)	MUTUAL TERMINATION AND RELEASE AGREEMENT Exhibit 10.7(a) MUTUAL TERMINATION AND RELEASE AGREEMENT This Mutual Termination and Release Agreement (?Release?) is entered into on January 28, 2010 (?Closing Date?) with an effective date of January 31, 2010 (?Effective Date?) between Health Discovery Corporation, a Georgia corporation (?HDC?), and DCL Medical Laboratories, LLC, a Delaware limited liability company (?DCL?), collectively referre
March 31, 2010	EX-10.16	NON-QUALIFIED STOCK OPTION AWARD OF HEALTH DISCOVERY CORPORATION Exhibit 10.16 NON-QUALIFIED STOCK OPTION AWARD OF HEALTH DISCOVERY CORPORATION THIS NON-QUALIFIED STOCK OPTION AWARD (the ?Award?) is made as of the Grant Date by HEALTH DISCOVERY CORPORATION, a corporation organized under the laws of the State of Georgia (the ?Company?) to (the ?Optionee?). Upon and subject to the Terms and Conditions attached hereto and incorporated herein by reference, the Comp

HDVY / Health Discovery Corporation - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)